´ëÇÑÀü¸³¼±ÇÐȸ 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷) : 2022-09-03±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀǽÇ
±³À°ÁÖÁ¦ :
(¿Â-¿ÀÇÁº´Çà) 2022 KPS-APSU Joint International Symposium(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÀü¸³¼±ÇÐȸ
´ã´çÀÚ : ¹èÁø¼º
¿¬¶ôó : 070-4336-5176
À̸ÞÀÏ :
gaonpco@gaonpco.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï - ±¹³»: 30000¿ø / ÇØ¿Ü: ¹«·áÇöÀåµî·Ï - ±¹³»: 40000¿ø / ÇØ¿Ü: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 09:00~09:30 Inherited Kidney Cancer Syndromes Brian M. SHUCH(UCLA USA)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 09:30~09:40 Evolving landscape of the Systemic Treatment for Metastatic Clear Cell RCC in the Era of Immunotherapy ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 09:40~09:50 Role of Metastasectomy for Metastatic RCC: Update ÃÖÁß¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 09:50~10:00 Treatment of Metastatic Non-Clear Cell RCC: Where Are We? ±èÁ¤ÁØ(°¡Å縯ÀÇ´ë)
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:00~10:15 Panel Discussion Edmund CHIONG(National University of Singapore)
ÈÞ½Ä 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:15~10:30 Coffee Break ()
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:30~10:40 Salvage Robotic-Assisted Radical Prostatectomy after Focal or Whole Gland Therapy: Is it Feasible? ÀÌÇйÎ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:40~10:50 BCR in 2022: What Test Can Be Done on Patients with Suspected BCR in the Era of Multi-Parametric MRI and PET-CT? ÃÖÀç´ö(À»ÁöÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 10:50~11:00 Extent of Pelvic Lymph Node Dissection during Radical Prostatectomy for Patients with Locally Advanced Prostate Cancer ±è¿øÅÂ(ÃæºÏÀÇ´ë)
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:00~11:15 Panel Discussion Bannakij LOJANAPIWAT(Chiangmai University Thailand)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:15~11:30 KPS BLUE Award ()
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 11:30~12:00 The First Reimbursed Option for mHSPC All-comers, Enzalutamide ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
½Ä»ç 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 12:00~13:00 Lunch ()
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:00~13:30 Update the Advanced Prostate Cancer Consortium: Controversies and Consensus Robert REITER(UCLA USA)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:30~13:40 Bipolar Androgen Therapy for Asymptomatic mCRPC: Myth or Reality? ¼¿øÀÍ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:40~13:50 Prevention of the Skeletal-Related Event with a Bone Protecting Agent for Patients with Bone Metastatic CRPC ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 13:50~14:00 PSMA Beyond Imaging ±èº´ÈÆ(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:00~14:15 Panel Discussion ÀÌÇö¹«(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:15~14:30 Coffee Break ()
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 14:30~15:00 Contemporary Management of MIBC: Systemic Therapy, Radical Cystectomy, and Bladder Sparing Seth LERNER(Baylor College of Medicine USA)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:00~15:15 The Role of Multi-Parametric MRI and VI-RADS for Local Staging of Muscle Invasive Bladder Cancer ¹Ú°èÁø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:15~15:25 Management of Distal Ureter during Nephroureterectomy for Upper Tract Urothelial Carcinoma ¼Û¿Ï(¼º±Õ°üÀÇ´ë)
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:25~15:35 Panel Discussion Teng Aik ONG(University of Malaya)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:35~15:45 Recent Updates in Treatment for Metastatic Testicular Germ Cell Tumor ÇÏÀ±¼®(°æºÏÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:45~15:55 Neoadjuvant Chemotherapy for Patients with Lymph Node-Positive Penile Cancer ¹ÚÈ«ÁÖ(°¿øÀÇ´ë)
±³À°½Ã°£ 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 15:55~16:05 Do Newer Minimally Invasive Surgical Interventions for BPH Affect Sexual Function of Patients? À̼ҿ¬(¸íÁöº´¿ø)
Åä·Ð 09-03 SCÄÁº¥¼Ç¼¾ÅÍ ÁöÇÏ 1Ãþ ±¹Á¦È¸ÀÇ½Ç 16:05~16:30 Panel Discussion È«ÁØÇõ(¿ï»êÀÇ´ë)